Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J H Porter

Showing results (181-190 of 298) with videos related to

Pageof 30
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 20, 2013
PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicinGemma M Ryan, Lisa M Kaminskas, Jürgen B Bulitta, et al.
Molecular Pharmaceutics|October 6, 2017
Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle ColloidsEstelle J A Suys, Dallas B Warren, Christopher J H Porter, et al.
Molecular Pharmaceutics|November 3, 2015
Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak BasesShasha Rao, Katharina Richter, Tri-Hung Nguyen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 22, 2009
Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MUKaren L White, Gary Nguyen, William N Charman, et al.
Molecular Pharmaceutics|April 9, 2008
The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimersLisa M Kaminskas, Ben J Boyd, Peter Karellas, et al.
RSC Advances|May 2, 2022
API ionic liquids: probing the effect of counterion structure on physical form and lipid solubilityLeigh Ford, Erin Tay, Tri-Hung Nguyen, et al.
Pharmaceutics|December 28, 2019
Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo ExposureErin Tay, Tri-Hung Nguyen, Leigh Ford, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 8, 2004
Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
Molecular Pharmaceutics|June 12, 2013
Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependentGemma M Ryan, Lisa M Kaminskas, Brian D Kelly, et al.
ACS Nano|January 31, 2015
Size and rigidity of cylindrical polymer brushes dictate long circulating properties in vivoMarkus Müllner, Sarah J Dodds, Tri-Hung Nguyen, et al.
Pageof 30

Showing results (181-190 of 298) with videos related to

Sort By:
Pageof 30
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 20, 2013
PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicinGemma M Ryan, Lisa M Kaminskas, Jürgen B Bulitta, et al.
Molecular Pharmaceutics|October 6, 2017
Computational Models of the Intestinal Environment. 3. The Impact of Cholesterol Content and pH on Mixed Micelle ColloidsEstelle J A Suys, Dallas B Warren, Christopher J H Porter, et al.
Molecular Pharmaceutics|November 3, 2015
Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak BasesShasha Rao, Katharina Richter, Tri-Hung Nguyen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 22, 2009
Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MUKaren L White, Gary Nguyen, William N Charman, et al.
Molecular Pharmaceutics|April 9, 2008
The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly l-lysine dendrimersLisa M Kaminskas, Ben J Boyd, Peter Karellas, et al.
RSC Advances|May 2, 2022
API ionic liquids: probing the effect of counterion structure on physical form and lipid solubilityLeigh Ford, Erin Tay, Tri-Hung Nguyen, et al.
Pharmaceutics|December 28, 2019
Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo ExposureErin Tay, Tri-Hung Nguyen, Leigh Ford, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 8, 2004
Lymphatic absorption is the primary contributor to the systemic availability of epoetin Alfa following subcutaneous administration to sheepDanielle N McLennan, Christopher J H Porter, Glenn A Edwards, et al.
Molecular Pharmaceutics|June 12, 2013
Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependentGemma M Ryan, Lisa M Kaminskas, Brian D Kelly, et al.
ACS Nano|January 31, 2015
Size and rigidity of cylindrical polymer brushes dictate long circulating properties in vivoMarkus Müllner, Sarah J Dodds, Tri-Hung Nguyen, et al.
Pageof 30